https://majorhealthnews.com/press-releases/halozyme-reaffirms-it-projects-zero-to-minimal-impact-to-royalty-revenue-through-at-leastMajor Health Newsen2026-11-06T15:16:45.619ZHalozyme Reaffirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Medicare Drug Price Negotiation Program Final Rule for IPAY 2029 https://majorhealthnews.com/press-releases/aligos-therapeutics-reports-recent-business-progress-and-third-quarter-2026-financialMajor Health Newsen2026-11-06T13:06:49.036ZAligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results